Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $2.7M | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $7.9M | $7.8M | $18.8M | $19.1M | $68.6M | $16.0M | $10.3M | $5.8M |
| Operating income | −$11.3M | −$11.9M | −$23.7M | −$20.5M | −$78.4M | $1.0M | −$34.8M | −$11.1M |
| EBITDA | −$10.7M | −$11.3M | −$12.3M | −$19.7M | −$92.8M | $5.9M | −$26.8M | −$10.5M |
| Net income | −$10.2M | −$9.2M | −$34.6M | −$23.3M | −$124.1M | $6.8M | −$50.8M | −$531.0K |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -38.66 | -27.19 | -68.75 | -35.64 | -151.98 | 6.15 | -36.00 | -0.20 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds BVXV.
No tracked institution reports a position in BVXV as of their last filing.
No one on the platform has traded BVXV yet.
| $4M |
| — |
| HILSHillstream BioPharma, Inc. | $0.24 | +5.66% | $4M | — |
| NBRVFNabriva Therapeutics plc | $0.00 | +0.00% | $323 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.